Table 5.
Enriched functional term clusters following DAVID analysis of genes identified by ROH analysis in candidate regions that were specific to the non-infected cohort and those that overlapped between at least two methods of detecting selection signatures.
Cluster | Score | Category | Term | Gene count | P-value | Genes | Benjamini | |
---|---|---|---|---|---|---|---|---|
ROH regions specific to non-infected cohorts = 51 genes | 1 | 2.19 | INTERPRO | IPR001325:Interleukin-4/interleukin-13 | 3 | 0.00003 | IL4, IL13 | 0.002 |
INTERPRO | IPR018096:Interleukin-4/interleukin-13, conserved site | 3 | 0.00003 | IL4, IL13 | 0.002 | |||
SMART | SM00190:IL4_13 | 3 | 0.00004 | IL4, IL13 | 0.002 | |||
KEGG | oas04060:Cytokine-cytokine receptor interaction | 6 | 0.00056 | IL4, CXCR1, CXCR2, IL13, AMH | 0.057 | |||
KEGG | oas05310:Asthma | 3 | 0.00638 | IL4, IL13 | 0.326 | |||
INTERPRO | IPR012351:Four-helical cytokine, core | 3 | 0.01402 | IL4, IL13 | 0.364 | |||
INTERPRO | IPR009079:Four-helical cytokine-like, core | 3 | 0.01551 | IL4, IL13 | 0.364 | |||
KEGG | oas04664:Fc epsilon RI signaling pathway | 3 | 0.01706 | IL4, IL13 | 0.580 | |||
KEGG | oas05321:Inflammatory bowel disease (IBD) | 3 | 0.02290 | IL4, IL13 | 0.584 | |||
KEGG | oas05162:Measles | 3 | 0.06509 | IL4, IL13 | 1.000 | |||
KEGG | oas04630:Jak-STAT signaling pathway | 3 | 0.09399 | IL4, IL13 | 1.000 | |||
UP_KEYWORDS | Signal | 8 | 0.52067 | IL4, PDF, CDH1, IL13, AMH, TMED6, TMCO1 | 1.000 | |||
GOTERM_CC | GO:0005615 extracellular space | 3 | 0.67367 | IL4, IL13 | 1.000 | |||
2 | 1.73 | KEGG | oas04060:Cytokine-cytokine receptor interaction | 6 | 0.00056 | IL4, CXCR1, CXCR2, IL13, AMH | 0.057 | |
UP_KEYWORDS | Growth factor | 4 | 0.00161 | IL4, PDGFD, AMH | 0.074 | |||
UP_KEYWORDS | Secreted | 3 | 0.32286 | IL4, AMH | 1.000 | |||
UP_KEYWORDS | Disulfide bond | 5 | 0.39333 | IL4, TMPRSS9, LOC101115991, AMH | 1.000 | |||
Overlapping genes = 56 genes (excluding ENSOARG genes | 1 | 3.00 | INTERPRO | IPR019826: Carboxylesterase type B, active site | 3 | 0.00022 | CES3, CES4A, CES2 | 0.028 |
INTERPRO | IPR002018:Carboxylesterase, type B | 3 | 0.00070 | CES3, CES4A, CES2 | 0.045 | |||
GOTERM_MF | GO:0016787 hydrolase activity | 4 | 0.00118 | CES3, NUDT6, CES4A, CES2 | 0.051 | |||
UP_KEYWORDS | Hydrolase | 7 | 0.00520 | DDX47, ATP10D, CES3, PCSK5, NUDT6, CES4A, CES2 | 0.192 |